• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA SYNTHETIC CARTILAGE IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA SYNTHETIC CARTILAGE IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Catalog Number CAR-10
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Osteolysis (2377); Insufficient Information (4580)
Event Date 01/11/2022
Event Type  Injury  
Manufacturer Narrative
Analysis results are not available at the time of this report.A follow-up report will be sent when the analysis is complete.
 
Event Description
It was reported that patient underwent a revision surgery to have the cartiva device removed and converted to a mtp1 fusion.
 
Manufacturer Narrative
Correction: g1 manufacturing site, h6 clinical, d4 part number and gtin the reported event could be confirmed, since the device was returned for evaluation confirming a revision surgery was performed.The device inspection revealed the following: the device was returned without any liquid, enclosed in a medical sample cup, and packed in a zip-lock pouch.The device had a yellow-ish hue, was translucent throughout its length, and was stiff to touch.The sides of the implant had dark red-brown spots.Upon visual examination, the articulating surface of the implant has a curved indentation with a consistent radius.One edge of the articulating top surface has irregular wear with a rough finish, and it's asymmetrical compared to the other side of the implant.The device was left in sterile saline over 8 days.After hydration, the device became more elastic.The diameter and height of the returned device were measured on a calibrated optical comparator at three different orientation and weighed three times on a calibrated scale, both before and after hydration.The height and diameter of the hydrated returned device are within the sterile specification for freshly manufactured car-10 device (9.45 mm returned vs 9.0-10.3 mm height specification) (10.33 mm returned vs 10.2-11.0 mm diameter specification).The wear observed on the edge of the articulating top surface is asymmetrical compared to the other side and has a rough surface finish.This is not consistent with the wear observed in the cartiva on cartilage wear study simulating 5 years of use.No further conclusion can be drawn without knowing the condition of the opposing cartilage / joint.No root cause of device removal can be determined due to the dehydration process that the returned device experienced.Our medical affairs contact reviewed the available information and provided imaging.Per their review, "the x-ray show extensive joint space narrowing and subchondral osteolysis in the head of the first metatarsal and in the proximal phalanx.This indicates end-stage osteoarthritis with involvement of the whole joint.In these circumstances the cartiva implants articulates with the rough surface of the proximal phalanx, explaining the roughening of this side of the cartiva implant.The osteoarthritic deformity of the mtp i joint causes subluxation, explains for the asymmetrical wear of the distal side of the implant.This case could be assessed in more detail if the pre-operative and early postoperative x-rays would come available." more detailed information about the complaint event as well as the affected device must be available in order to determine the root cause of the complaint event.A review of the device history was not possible because the lot number was not communicated.No corrective actions are required at this time.A review of the labeling did not indicate any abnormalities.No indications of material, manufacturing or design related problems were found during the investigation.If any additional information is provided, the investigation will be reassessed.
 
Event Description
It was reported that patient underwent a revision surgery to have the cartiva device removed and converted to a mtp1 fusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA SYNTHETIC CARTILAGE IMPLANT
Type of Device
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer (Section G)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
Manufacturer Contact
anna jusinski
325 corporate drive
mahwah, NJ 07430
2018315000
MDR Report Key13486166
MDR Text Key287426769
Report Number3009351194-2022-00001
Device Sequence Number1
Product Code PNW
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P150017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue NumberCAR-10
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/13/2022
Initial Date FDA Received02/08/2022
Supplement Dates Manufacturer Received05/12/2022
Supplement Dates FDA Received06/07/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age50 YR
Patient SexFemale
-
-